secwatch.observer — SEC 8-K summary
======================================

Issuer:     Definium Therapeutics, Inc. (DFTX)
CIK:        0001813814
Form:       8-K
Filed at:   2025-10-31T23:59:59+00:00
Accession:  0001104659-25-104696
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MindMed prices $225M public offering of 18.375M shares at $12.25/sh; upsize to $258.9M after full over-allotment
--------------------------------------------------------------------------------

- Issued 18,375,000 common shares at $12.25 per share; underwriters exercised option for additional 2,756,250 shares.
- Gross proceeds of $258.9M; net proceeds of $242.8M after underwriting discounts and estimated expenses.
- Offering closed October 31, 2025; Jefferies, Leerink Partners, Evercore ISI as joint bookrunners.
- Net proceeds to fund R&D of product candidates, working capital, and potential complementary acquisitions.
- Directors and executive officers subject to 90-day lock-up on share sales without consent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1813814/000110465925104696/0001104659-25-104696-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1813814/000110465925104696/tm2529910d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-104696

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer